Metraipolis › archive › dc_11b15b1bfca2

Ipilimumab, -omics, and head and neck cancers-update in 2025 — Europe PMC PMID:41836369

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41836369
DOI
10.3389/fimmu.2026.1737862
License (as archived)
solo-consultazione
Archived
2026-11-05T13:04:02.191Z
SHA-256 of the archived text
60de05e0554b9a609e6aa34b7d1c937bcf3d1021e2b16f38d164e69419468401
Stable URL of this page
https://metraipolis.com/documento/dc_11b15b1bfca2

How to cite

Ipilimumab, -omics, and head and neck cancers-update in 2025 — Europe PMC PMID:41836369 — Europe PMC (en), https://europepmc.org/article/MED/41836369 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_11b15b1bfca2 (Metraipolis archive dc_11b15b1bfca2, sha256 60de05e0554b9a609e6aa34b7d1c937bcf3d1021e2b16f38d164e69419468401)
BibTeX
@misc{dc11b15b1bfca2,
  title = {Ipilimumab, -omics, and head and neck cancers-update in 2025 — Europe PMC PMID:41836369},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41836369},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_11b15b1bfca2; sha256 60de05e0554b9a609e6aa34b7d1c937bcf3d1021e2b16f38d164e69419468401},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41836369. Agents can read the archived copy with the MCP tool read_document.